These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38897543)

  • 21. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis.
    Vakil K; Duval S; Sharma A; Adabag S; Abidi KS; Taimeh Z; Colvin-Adams M
    Int J Cardiol; 2014 Oct; 176(3):595-9. PubMed ID: 25305706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing.
    Alnsasra H; Perue RK; Khalil F; Regev O; Kushwaha SS; Briasoulis A; Asleh R
    J Thorac Cardiovasc Surg; 2024 Mar; ():. PubMed ID: 38452886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation.
    Gulati G; Ruthazer R; Denofrio D; Vest AR; Kent D; Kiernan MS
    J Card Fail; 2021 May; 27(5):552-559. PubMed ID: 33450411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple echocardiographic method to estimate pulmonary vascular resistance.
    Opotowsky AR; Clair M; Afilalo J; Landzberg MJ; Waxman AB; Moko L; Maron BA; Vaidya A; Forfia PR
    Am J Cardiol; 2013 Sep; 112(6):873-82. PubMed ID: 23735649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Implications of Baseline Pulmonary Vascular Resistance Determined by Transthoracic Echocardiography Before Transcatheter Aortic Valve Replacement.
    Rozenbaum Z; Topilsky Y; Biner S; Steinvil A; Arbel Y; Bazan S; Banai S; Finkelstein A; Halkin A
    J Am Soc Echocardiogr; 2019 Jun; 32(6):737-743.e1. PubMed ID: 31043360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    Drakos SG; Kfoury AG; Gilbert EM; Horne BD; Long JW; Stringham JC; Campbell BA; Renlund DG
    J Heart Lung Transplant; 2007 Apr; 26(4):319-23. PubMed ID: 17403471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.
    Xu J; Wang JJ; Zhao QH; Gong SG; Wu WH; Jiang R; Luo CJ; Qiu HL; Li HT; Wang L; Liu JM
    J Hypertens; 2024 Oct; 42(10):1703-1710. PubMed ID: 38860405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation.
    Daftari B; Alejos JC; Perens G
    J Transplant; 2010; 2010():656984. PubMed ID: 20224752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S; Wenzelburger F; Stypmann J; Welp H; Drees G; Schmid C; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in right ventricular morphology, not function, indicate the nature of increased afterload in pulmonary hypertensive subjects with normal left ventricular function.
    Raza F; Dillane C; Mirza A; Brailovsky Y; Weaver S; Keane MG; Forfia P
    Echocardiography; 2017 Nov; 34(11):1584-1592. PubMed ID: 28942616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indexed donor cardiac output for improved size matching in heart transplantation: A United Network for Organ Sharing database analysis.
    Pasrija C; Kon ZN; Shah A; Holmes SD; Rozenberg KS; Joseph S; Griffith BP
    JTCVS Open; 2023 Sep; 15():291-299. PubMed ID: 37808019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.
    Maron BA; Brittain EL; Hess E; Waldo SW; Barón AE; Huang S; Goldstein RH; Assad T; Wertheim BM; Alba GA; Leopold JA; Olschewski H; Galiè N; Simonneau G; Kovacs G; Tedford RJ; Humbert M; Choudhary G
    Lancet Respir Med; 2020 Sep; 8(9):873-884. PubMed ID: 32730752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated pre-transplant pulmonary vascular resistance is associated with early post-transplant atrial fibrillation and mortality.
    Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Darche FF; Thomas D; Bruckner T; Doesch AO; Katus HA; Ehlermann P
    ESC Heart Fail; 2020 Feb; 7(1):176-187. PubMed ID: 32197001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome.
    Bellettini M; Frea S; Pidello S; Boffini M; Boretto P; Gallone G; Bongiovanni F; Masetti M; Sabatino M; Raineri C; Pacini D; Martin Suarez S; Loforte A; Rinaldi M; Potena L; De Ferrari GM
    J Card Fail; 2022 Feb; 28(2):259-269. PubMed ID: 34509597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain death alters cardiopulmonary hemodynamics and impairs right ventricular power reserve against an elevation of pulmonary vascular resistance.
    Bittner HB; Chen EP; Kendall SW; Van Trigt P
    Chest; 1997 Mar; 111(3):706-11. PubMed ID: 9118712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications.
    Panaioli E; Birritella L; Graziani F; Lillo R; Grandinetti M; Di Molfetta A; Przybylek B; Lombardo A; Lanza GA; Secinaro A; Perri G; Amodeo A; Massetti M; Crea F; Delogu AB
    Arch Cardiovasc Dis; 2022 Feb; 115(2):67-77. PubMed ID: 35125276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological testing of the reversibility of increased pulmonary vascular resistance before heart transplantation with prostaglandin I2 (prostacyclin)].
    Trautnitz M; Pehlivanli S; Behr J; Schwaiblmair M; Uberfuhr P; Meiser B; von Scheidt W
    Z Kardiol; 1999 Feb; 88(2):133-40. PubMed ID: 10209834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary vascular resistance versus pulmonary artery pressure for predicting right ventricular remodeling and functional tricuspid regurgitation.
    Gual-Capllonch F; Teis A; Ferrer E; Núñez J; Vallejo N; Juncà G; López-Ayerbe J; Lupón J; Bayes-Genis A
    Echocardiography; 2018 Nov; 35(11):1736-1745. PubMed ID: 30136745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Assist Devices in Pulmonary Hypertension Group 2 With Significantly Elevated Pulmonary Vascular Resistance: A Bridge to Cure.
    Selim AM; Wadhwani L; Burdorf A; Raichlin E; Lowes B; Zolty R
    Heart Lung Circ; 2019 Jun; 28(6):946-952. PubMed ID: 29895486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.